1,2-dimethylhydrazine increases expression ISO RGD:1551007 6480464 1, 2-Dimethylhydrazine results in increased expression of CCL7 mRNA CTD PMID:22206623 1,4-phenylenediamine increases expression ISO RGD:1352377 6480464 4-phenylenediamine results in increased expression of CCL7 mRNA CTD PMID:27585668 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of CCL7 mRNA CTD PMID:21893156 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1551007 6480464 Dinitrochlorobenzene results in increased expression of CCL7 mRNA CTD PMID:19647056 , PMID:21404309 15-acetyldeoxynivalenol increases expression ISO RGD:1551007 6480464 15-acetyldeoxynivalenol results in increased expression of CCL7 mRNA CTD PMID:24793808 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CCL7 mRNA CTD PMID:15212814 17beta-estradiol affects expression ISO RGD:1551007 6480464 Estradiol affects the expression of CCL7 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL7 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:1551007 6480464 Estradiol results in increased expression of CCL7 mRNA CTD PMID:19484750 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CCL7 mRNA CTD PMID:17010207 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL7 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1352377 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1352377 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551007 6480464 Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CCL7 mRNA] CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CCL7 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551007 6480464 Tetrachlorodibenzodioxin results in increased expression of CCL7 mRNA CTD PMID:29673856 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551007 6480464 Tetrachlorodibenzodioxin affects the expression of CCL7 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352377 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCL7 mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551007 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCL7 mRNA CTD PMID:19933214 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1551007 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CCL7 mRNA CTD PMID:17982090 2,4-dinitrobenzenesulfonic acid increases expression ISO RGD:1551007 6480464 2, 4-dinitrobenzenesulfonic acid results in increased expression of CCL7 mRNA CTD PMID:30116771 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CCL7 protein CTD PMID:25051504 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL7 mRNA], IL1B promotes the reaction [Glucosamine results in increased expression of CCL7 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of CCL7 mRNA CTD PMID:17109745 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine affects expression EXP 6480464 Puromycin Aminonucleoside affects the expression of CCL7 mRNA CTD PMID:10867541 3-acetyldeoxynivalenol increases expression ISO RGD:1551007 6480464 3-acetyldeoxynivalenol results in increased expression of CCL7 mRNA CTD PMID:24793808 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1551007 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL7 mRNA more ... CTD PMID:16054899 , PMID:23503329 3-methylcholanthrene increases expression ISO RGD:1551007 6480464 Methylcholanthrene results in increased expression of CCL7 mRNA CTD PMID:20713471 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of CCL7 mRNA CTD PMID:21893156 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1551007 6480464 Oxazolone results in increased expression of CCL7 mRNA CTD PMID:19647056 , PMID:21404309 4-hydroxynon-2-enal decreases expression ISO RGD:1551007 6480464 4-hydroxy-2-nonenal results in decreased expression of CCL7 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1551007 6480464 Fenretinide results in increased expression of CCL7 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide increases expression ISO RGD:1551007 6480464 4-Nitroquinoline-1-oxide results in increased expression of CCL7 mRNA CTD PMID:22561872 acetamide increases expression EXP 6480464 acetamide results in increased expression of CCL7 mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:1352377 6480464 Aflatoxin B1 results in decreased methylation of CCL7 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CCL7 mRNA CTD PMID:25378103 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL7 mRNA], IL1B promotes the reaction [Glucosamine results in increased expression of CCL7 mRNA] CTD PMID:17109745 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of CCL7 mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression ISO RGD:1352377 6480464 Tretinoin results in increased expression of CCL7 mRNA, Tretinoin results in increased expression of CCL7 protein CTD PMID:19828696 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:1352377 6480464 [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL7 mRNA, [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL7 protein CTD PMID:19828696 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CCL7 mRNA CTD PMID:16483693 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of CCL7 mRNA CTD PMID:22168577 apocynin multiple interactions ISO RGD:1352377 6480464 acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA] CTD PMID:22414048 arsane increases expression EXP 6480464 Arsenic results in increased expression of CCL7 mRNA CTD PMID:18315880 arsane multiple interactions ISO RGD:1352377 6480464 [Arsenic results in increased abundance of Arsenicals] which affects the expression of CCL7 mRNA CTD PMID:28793237 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of CCL7 mRNA CTD PMID:18315880 arsenic atom multiple interactions ISO RGD:1352377 6480464 [Arsenic results in increased abundance of Arsenicals] which affects the expression of CCL7 mRNA CTD PMID:28793237 arsenous acid multiple interactions ISO RGD:1352377 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL7 mRNA, [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL7 protein CTD PMID:19828696 arsenous acid increases expression ISO RGD:1352377 6480464 Arsenic Trioxide results in increased expression of CCL7 mRNA, Arsenic Trioxide results in increased expression of CCL7 protein CTD PMID:19828696 asperentin decreases expression ISO RGD:1551007 6480464 cladosporin results in decreased expression of CCL7 mRNA CTD PMID:19818335 astemizole decreases expression EXP 6480464 Astemizole results in decreased expression of CCL7 mRNA CTD PMID:20221588 atrazine multiple interactions ISO RGD:1352377 6480464 [Atrazine co-treated with Arsenates] results in increased expression of CCL7 mRNA CTD PMID:18585445 atrazine increases expression ISO RGD:1352377 6480464 Atrazine results in increased expression of CCL7 mRNA CTD PMID:22378314 barium sulfate increases expression EXP 6480464 Barium Sulfate results in increased expression of CCL7 mRNA CTD PMID:29463257 benzalkonium chloride increases expression ISO RGD:1551007 6480464 Benzalkonium Compounds results in increased expression of CCL7 mRNA, Benzalkonium Compounds results in increased expression of CCL7 protein CTD PMID:30171875 , PMID:30517752 benzo[a]pyrene affects expression ISO RGD:1352377 6480464 Benzo(a)pyrene affects the expression of CCL7 mRNA CTD PMID:22316170 benzo[a]pyrene decreases expression ISO RGD:1551007 6480464 Benzo(a)pyrene results in decreased expression of CCL7 mRNA CTD PMID:32417428 benzo[a]pyrene increases expression ISO RGD:1551007 6480464 Benzo(a)pyrene results in increased expression of CCL7 mRNA CTD PMID:22228805 , PMID:23735875 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL7 mRNA], IL1B promotes the reaction [Glucosamine results in increased expression of CCL7 mRNA] CTD PMID:17109745 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of CCL7 mRNA CTD PMID:17109745 bis(2-chloroethyl) sulfide increases expression ISO RGD:1551007 6480464 Mustard Gas results in increased expression of CCL7 mRNA CTD PMID:15674843 bis(2-chloroethyl) sulfide increases secretion ISO RGD:1352377 6480464 Mustard Gas results in increased secretion of CCL7 protein CTD PMID:33491125 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CCL7 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases expression ISO RGD:1551007 6480464 bisphenol A results in increased expression of CCL7 mRNA CTD PMID:32144343 bisphenol A multiple interactions ISO RGD:1551007 6480464 [Ovalbumin co-treated with bisphenol A] results in increased expression of and results in increased secretion of CCL7 protein CTD PMID:29737898 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CCL7 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression ISO RGD:1352377 6480464 bisphenol A results in increased expression of CCL7 mRNA CTD PMID:29275510 bleomycin A2 decreases expression ISO RGD:1551007 6480464 Bleomycin results in decreased expression of CCL7 mRNA CTD PMID:29720568 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of CCL7 mRNA CTD PMID:32479839 butanal increases expression ISO RGD:1352377 6480464 butyraldehyde results in increased expression of CCL7 mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions ISO RGD:1551007 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of CCL7 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA] CTD PMID:25451590 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CCL7 mRNA CTD PMID:19167457 , PMID:20471445 Calcimycin increases expression ISO RGD:1551007 6480464 Calcimycin results in increased expression of CCL7 mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:1551007 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA] CTD PMID:25451590 calcium atom increases uptake ISO RGD:1352377 6480464 CCL7 protein results in increased uptake of Calcium CTD PMID:10984371 calcium atom multiple interactions ISO RGD:1352377 6480464 Piperidines analog inhibits the reaction [CCL7 protein results in increased uptake of Calcium] CTD PMID:10843593 calcium(0) increases uptake ISO RGD:1352377 6480464 CCL7 protein results in increased uptake of Calcium CTD PMID:10984371 calcium(0) multiple interactions ISO RGD:1352377 6480464 Piperidines analog inhibits the reaction [CCL7 protein results in increased uptake of Calcium] CTD PMID:10843593 cannabidiol decreases expression ISO RGD:1551007 6480464 Cannabidiol results in decreased expression of CCL7 mRNA CTD PMID:21542829 cannabidiol multiple interactions ISO RGD:1352377 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA] CTD PMID:31250491 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of CCL7 mRNA CTD PMID:20211217 carbon nanotube increases expression ISO RGD:1551007 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1352377 6480464 Nanotubes, Carbon results in increased expression of CCL7 mRNA CTD PMID:29348435 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of CCL7 mRNA CTD PMID:19836432 , PMID:24911292 ceric oxide increases expression EXP 6480464 ceric oxide results in increased expression of CCL7 mRNA CTD PMID:29463257 CGP 52608 multiple interactions ISO RGD:1352377 6480464 CGP 52608 promotes the reaction [RORA protein binds to CCL7 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:1551007 6480464 EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of CCL7 mRNA] CTD PMID:21224055 chenodeoxycholic acid increases expression ISO RGD:1551007 6480464 Chenodeoxycholic Acid results in increased expression of CCL7 mRNA CTD PMID:21224055 cholesterol multiple interactions ISO RGD:1551007 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CCL7 mRNA CTD PMID:22129739 choline multiple interactions ISO RGD:1551007 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL7 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CCL7 mRNA CTD PMID:22023808 cobalt atom multiple interactions ISO RGD:1551007 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA] CTD PMID:23503329 copper atom decreases expression EXP 6480464 Copper results in decreased expression of CCL7 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of CCL7 mRNA CTD PMID:30556269 cyclophosphamide increases expression ISO RGD:1551007 6480464 Cyclophosphamide results in increased expression of CCL7 mRNA CTD PMID:15331540 , PMID:21041162 cyclosporin A increases expression ISO RGD:1551007 6480464 Cyclosporine results in increased expression of CCL7 mRNA CTD PMID:23958496 cypermethrin multiple interactions ISO RGD:1551007 6480464 cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of CCL7 mRNA] CTD PMID:29471534 deoxycholic acid increases expression ISO RGD:1551007 6480464 Deoxycholic Acid results in increased expression of CCL7 mRNA CTD PMID:21224055 deoxycholic acid multiple interactions ISO RGD:1551007 6480464 EGR1 promotes the reaction [Deoxycholic Acid results in increased expression of CCL7 mRNA] CTD PMID:21224055 deoxynivalenol multiple interactions ISO RGD:1551007 6480464 Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL7 mRNA] CTD PMID:15681167 deoxynivalenol increases expression ISO RGD:1551007 6480464 deoxynivalenol results in increased expression of CCL7 mRNA CTD PMID:15371230 more ... dexamethasone multiple interactions ISO RGD:1551007 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL7 mRNA more ... CTD PMID:16054899 , PMID:23503329 dexamethasone decreases expression ISO RGD:1551007 6480464 Dexamethasone results in decreased expression of CCL7 mRNA CTD PMID:22733784 dextran sulfate increases expression ISO RGD:1551007 6480464 Dextran Sulfate results in increased expression of CCL7 mRNA CTD PMID:19645018 , PMID:32033881 dextran sulfate multiple interactions ISO RGD:1551007 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL7 mRNA, Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of CCL7 mRNA] CTD PMID:29950665 , PMID:32033881 diarsenic trioxide multiple interactions ISO RGD:1352377 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL7 mRNA, [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL7 protein CTD PMID:19828696 diarsenic trioxide increases expression ISO RGD:1352377 6480464 Arsenic Trioxide results in increased expression of CCL7 mRNA, Arsenic Trioxide results in increased expression of CCL7 protein CTD PMID:19828696 dichlorine increases expression ISO RGD:1551007 6480464 Chlorine results in increased expression of CCL7 mRNA CTD PMID:30189237 dichromium trioxide increases secretion ISO RGD:1352377 6480464 chromic oxide analog results in increased secretion of CCL7 protein CTD PMID:24885771 diethyl malate affects expression ISO RGD:1551007 6480464 diethyl malate affects the expression of CCL7 mRNA CTD PMID:24814887 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CCL7 mRNA CTD PMID:17010207 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CCL7 mRNA CTD PMID:21658437 dioxygen multiple interactions ISO RGD:1551007 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL7 mRNA CTD PMID:30529165 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CCL7 mRNA CTD PMID:20211217 doxorubicin decreases expression ISO RGD:1352377 6480464 Doxorubicin results in decreased expression of CCL7 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CCL7 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:1551007 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CCL7 mRNA CTD PMID:30517762 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CCL7 mRNA CTD PMID:30307764 ferric oxide increases secretion ISO RGD:1352377 6480464 ferric oxide results in increased secretion of CCL7 protein CTD PMID:24885771 ferric oxide multiple interactions ISO RGD:1551007 6480464 ferric oxide results in increased expression of and results in increased secretion of CCL7 protein CTD PMID:34982504 flumequine multiple interactions ISO RGD:1551007 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 fluoranthene multiple interactions ISO RGD:1551007 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA] CTD PMID:28329830 folic acid multiple interactions ISO RGD:1551007 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL7 mRNA CTD PMID:20938992 folic acid increases expression ISO RGD:1551007 6480464 Folic Acid results in increased expression of CCL7 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of CCL7 mRNA CTD PMID:27387713 Fusarenone X increases expression ISO RGD:1551007 6480464 fusarenon-X results in increased expression of CCL7 mRNA CTD PMID:24793808 gadodiamide hydrate increases expression EXP 6480464 gadodiamide results in increased expression of CCL7 protein CTD PMID:20938346 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CCL7 protein CTD PMID:25051504 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CCL7 mRNA CTD PMID:33387578 gold atom multiple interactions ISO RGD:1551007 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein CTD PMID:22155353 gold atom increases secretion ISO RGD:1551007 6480464 Gold results in increased secretion of CCL7 protein CTD PMID:22155353 gold(0) multiple interactions ISO RGD:1551007 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein CTD PMID:22155353 gold(0) increases secretion ISO RGD:1551007 6480464 Gold results in increased secretion of CCL7 protein CTD PMID:22155353 graphene oxide increases expression ISO RGD:1551007 6480464 graphene oxide results in increased expression of CCL7 mRNA CTD PMID:33227293 GW 4064 increases expression ISO RGD:1551007 6480464 GW 4064 results in increased expression of CCL7 mRNA CTD PMID:26655953 hydrogen peroxide increases expression ISO RGD:1352377 6480464 Hydrogen Peroxide results in increased expression of CCL7 mRNA CTD PMID:32949572 hydrogen peroxide increases expression ISO RGD:1551007 6480464 Hydrogen Peroxide results in increased expression of CCL7 mRNA CTD PMID:35123994 iodixanol increases expression ISO RGD:1551007 6480464 iodixanol results in increased expression of CCL7 protein CTD PMID:34774977 isoprenaline decreases expression ISO RGD:1352377 6480464 Isoproterenol results in decreased expression of CCL7 mRNA CTD PMID:24286936 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of CCL7 mRNA CTD PMID:20211217 , PMID:24286936 L-methionine multiple interactions ISO RGD:1551007 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL7 mRNA CTD PMID:20938992 lipopolysaccharide increases secretion ISO RGD:1352377 6480464 Lipopolysaccharides results in increased secretion of CCL7 protein CTD PMID:32800949 lipopolysaccharide increases expression ISO RGD:1551007 6480464 Lipopolysaccharides results in increased expression of CCL7 mRNA CTD PMID:22169119 more ... lipopolysaccharide multiple interactions ISO RGD:1551007 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL7 mRNA] more ... CTD PMID:22169119 more ... lipopolysaccharide multiple interactions ISO RGD:1352377 6480464 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL7 protein] more ... CTD PMID:18437699 more ... manganese atom increases expression ISO RGD:1352377 6480464 Manganese results in increased expression of CCL7 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1352377 6480464 Manganese results in increased expression of CCL7 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1352377 6480464 manganese chloride results in increased expression of CCL7 mRNA CTD PMID:17175027 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CCL7 mRNA CTD PMID:28801915 MeIQx multiple interactions ISO RGD:1551007 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 mercury atom multiple interactions ISO RGD:1551007 6480464 [MT3 protein affects the susceptibility to Mercury] which affects the expression of CCL7 mRNA CTD PMID:30103553 mercury(0) multiple interactions ISO RGD:1551007 6480464 [MT3 protein affects the susceptibility to Mercury] which affects the expression of CCL7 mRNA CTD PMID:30103553 metacetamol decreases expression ISO RGD:1551007 6480464 3-hydroxyacetanilide results in decreased expression of CCL7 mRNA CTD PMID:18544908 metformin multiple interactions ISO RGD:1551007 6480464 Metformin inhibits the reaction [IL13 protein results in increased expression of CCL7 mRNA] CTD PMID:26497364 methylmercury chloride increases expression ISO RGD:1551007 6480464 methylmercuric chloride results in increased expression of CCL7 mRNA CTD PMID:24213012 , PMID:30103553 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CCL7 mRNA CTD PMID:31378766 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of CCL7 mRNA CTD PMID:21515302 mycophenolic acid decreases expression ISO RGD:1551007 6480464 Mycophenolic Acid results in decreased expression of CCL7 mRNA CTD PMID:19818335 mycotoxin decreases expression ISO RGD:1551007 6480464 Mycotoxins results in decreased expression of CCL7 mRNA CTD PMID:19818335 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CCL7 mRNA CTD PMID:28801915 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CCL7 protein CTD PMID:17719030 naphthalene increases expression ISO RGD:1551007 6480464 naphthalene results in increased expression of CCL7 mRNA CTD PMID:18978301 neocuproine multiple interactions ISO RGD:1551007 6480464 neocuproine inhibits the reaction [lipopolysaccharide more ... CTD PMID:23604539 neoechinulin A decreases expression ISO RGD:1551007 6480464 neoechinulin A results in decreased expression of CCL7 mRNA CTD PMID:19818335 nickel atom increases expression ISO RGD:1352377 6480464 Nickel results in increased expression of CCL7 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom multiple interactions ISO RGD:1551007 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA] CTD PMID:23503329 nickel dichloride multiple interactions ISO RGD:1352377 6480464 [nickel chloride co-treated with Lipopolysaccharides] results in increased secretion of CCL7 protein more ... CTD PMID:18437699 , PMID:23090859 nickel dichloride decreases secretion ISO RGD:1352377 6480464 nickel chloride results in decreased secretion of CCL7 protein CTD PMID:18437699 nickel sulfate increases expression ISO RGD:1551007 6480464 nickel sulfate results in increased expression of CCL7 mRNA CTD PMID:16166746 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CCL7 mRNA CTD PMID:25729387 ozone increases response to substance ISO RGD:1551007 6480464 CCL7 protein results in increased susceptibility to Ozone CTD PMID:11777981 ozone multiple interactions ISO RGD:1551007 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CCL7 mRNA more ... CTD PMID:25658374 , PMID:34911549 ozone increases expression ISO RGD:1551007 6480464 Ozone results in increased expression of CCL7 mRNA, Ozone results in increased expression of CCL7 protein CTD PMID:11777981 more ... paracetamol multiple interactions ISO RGD:1551007 6480464 CCR2 protein affects the reaction [Acetaminophen results in increased expression of CCL7 protein], MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CCL7 mRNA] CTD PMID:11981759 , PMID:18700144 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CCL7 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:1551007 6480464 Acetaminophen affects the expression of CCL7 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1551007 6480464 Acetaminophen results in increased expression of CCL7 mRNA, Acetaminophen results in increased expression of CCL7 protein CTD PMID:11981759 , PMID:18544908 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CCL7 mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:1352377 6480464 pentanal results in increased expression of CCL7 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1352377 6480464 perfluorooctane sulfonic acid results in decreased expression of CCL7 mRNA CTD PMID:32219433 perfluorooctane-1-sulfonic acid decreases secretion ISO RGD:1352377 6480464 perfluorooctane sulfonic acid results in decreased secretion of CCL7 protein CTD PMID:32219433 perfluorooctanoic acid decreases expression ISO RGD:1352377 6480464 perfluorooctanoic acid results in decreased expression of CCL7 mRNA CTD PMID:32219433 perfluorooctanoic acid decreases secretion ISO RGD:1352377 6480464 perfluorooctanoic acid results in decreased secretion of CCL7 protein CTD PMID:32219433 pioglitazone multiple interactions ISO RGD:1551007 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CCL7 mRNA CTD PMID:27935865 piperidines multiple interactions ISO RGD:1352377 6480464 Piperidines analog inhibits the reaction [CCL7 protein results in increased uptake of Calcium] CTD PMID:10843593 polymyxin B2 multiple interactions ISO RGD:1551007 6480464 Polymyxin B inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL7 protein] CTD PMID:26882889 potassium dichromate increases expression ISO RGD:1551007 6480464 Potassium Dichromate results in increased expression of CCL7 mRNA CTD PMID:23608068 procyanidin B3 multiple interactions ISO RGD:1551007 6480464 [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL7 mRNA] CTD PMID:22169119 propanal increases expression ISO RGD:1352377 6480464 propionaldehyde results in increased expression of CCL7 mRNA CTD PMID:26079696 quartz increases expression EXP 6480464 Quartz results in increased expression of CCL7 mRNA CTD PMID:19836432 , PMID:32976597 quartz multiple interactions EXP 6480464 Tobacco Smoke Pollution promotes the reaction [Quartz results in increased expression of CCL7 mRNA] CTD PMID:32976597 resveratrol increases expression ISO RGD:1551007 6480464 resveratrol results in increased expression of CCL7 mRNA CTD PMID:11588890 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1352377 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCL7 mRNA CTD PMID:35811015 SB 203580 multiple interactions ISO RGD:1551007 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA] CTD PMID:28329830 Shikonin multiple interactions ISO RGD:1551007 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of CCL7 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA] CTD PMID:25451590 silicon dioxide decreases expression ISO RGD:1352377 6480464 Silicon Dioxide analog results in decreased expression of CCL7 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CCL7 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:1551007 6480464 Silicon Dioxide results in increased expression of CCL7 mRNA CTD PMID:23221170 , PMID:29341224 silicon dioxide multiple interactions ISO RGD:1551007 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein CTD PMID:22155353 silver atom decreases expression ISO RGD:1551007 6480464 Silver results in decreased expression of CCL7 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1551007 6480464 Silver results in decreased expression of CCL7 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:1352377 6480464 sodium arsenite results in increased expression of CCL7 mRNA CTD PMID:28595984 sodium arsenite affects expression ISO RGD:1352377 6480464 sodium arsenite affects the expression of CCL7 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1551007 6480464 sodium arsenite results in increased expression of CCL7 mRNA CTD PMID:21911445 succimer multiple interactions ISO RGD:1551007 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL7 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL7 mRNA CTD PMID:21641980 , PMID:26378955 tacrolimus hydrate increases expression ISO RGD:1551007 6480464 Tacrolimus results in increased expression of CCL7 mRNA CTD PMID:23958496 , PMID:29362864 tamoxifen decreases expression ISO RGD:1551007 6480464 Tamoxifen results in decreased expression of CCL7 mRNA CTD PMID:25123088 taurocholic acid multiple interactions ISO RGD:1551007 6480464 EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CCL7 mRNA] CTD PMID:21224055 taurocholic acid increases expression ISO RGD:1551007 6480464 Taurocholic Acid results in increased expression of CCL7 mRNA CTD PMID:21224055 testosterone decreases expression ISO RGD:1551007 6480464 Testosterone results in decreased expression of CCL7 mRNA CTD PMID:19693291 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL7 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1551007 6480464 Carbon Tetrachloride results in increased expression of CCL7 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1551007 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CCL7 mRNA CTD PMID:30517762 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CCL7 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CCL7 mRNA, Thioacetamide results in increased expression of CCL7 protein CTD PMID:25051504 , PMID:34492290 titanium dioxide increases expression ISO RGD:1551007 6480464 titanium dioxide results in increased expression of CCL7 mRNA CTD PMID:19464567 more ... titanium dioxide multiple interactions ISO RGD:1551007 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL7 mRNA CTD PMID:29950665 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CCL7 mRNA CTD PMID:30012374 titanium dioxide decreases expression ISO RGD:1551007 6480464 titanium dioxide results in decreased expression of CCL7 mRNA CTD PMID:29264374 toluene 2,4-diisocyanate increases expression ISO RGD:1551007 6480464 Toluene 2, 4-Diisocyanate results in increased expression of CCL7 mRNA CTD PMID:19647056 , PMID:21404309 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CCL7 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CCL7 mRNA CTD PMID:25729387 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of CCL7 mRNA CTD PMID:21683754 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CCL7 mRNA CTD PMID:33387578 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of CCL7 mRNA CTD PMID:21893156 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CCL7 mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:1352377 6480464 Valproic Acid results in decreased methylation of CCL7 gene CTD PMID:29154799 XL147 multiple interactions ISO RGD:1551007 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL7 mRNA CTD PMID:27935865 zinc atom multiple interactions ISO RGD:1551007 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA] CTD PMID:23503329 zinc(0) multiple interactions ISO RGD:1551007 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA] CTD PMID:23503329
